Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compounds as rearranged during transfection (RET) inhibitors

Compounds as rearranged during transfection (RET) inhibitors

US Patent 9879021 · Granted Jan 30, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

SGLT2/DPP4 inhibitor and application thereof2025
Spiro compound serving as ERK inhibitor, and application thereof2025
SGLTS/DPP4 inhibitor and application thereof2025
BRD4 inhibitor compound in solid form and preparation method therefor and use th2025
Azaindole derivative and use thereof as FGFR and C-Met inhibitor2025
Glucoside derivative that acts as SGLT1 inhibitor and application thereof2025
Transglutaminase 2 (TG2) inhibitors2024
Macrocyclic derivatives acting as XIa factor inhibitor2024
Pyrrolidinyl urea derivatives and application thereof in TrkA-related diseases2024
2,3-dihydro-1H-pyrrolizine-7-formamide derivative and application thereof2024
Diarylthiohydantoin compound as androgen receptor antagonist2024
2-amino-quinoline derivatives2023